Entities / Company
Elevance Health, Inc..
American healthcare company
- Reports this week
- 0
- Active events
- 0
- Connections
- 68
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
-
Morgan Stanley issued a research note on Elevance Health shares as the company filed its 13F reports with the SEC.Some support1 report
-
Elevance Health offers services through Carelon brand.Well supported5 reports1 development inside
-
Robeco Institutional Asset Management B.V. lifted its stake in Elevance Health shares and filed a 13F with the SEC.Some support2 reports
-
CMS rating changes affect major insurers like Humana, Centene, and Elevance, leading to legal challenges and financial adjustments.Well supported9 reports4 developments inside
One to three months ago
-
Truist Financial raised its price objective and issued a buy rating for Elevance Health, Inc. on July 4, 2026.Some support4 reports
-
A legal firm is operating in New York involving the company Elevance Health, Inc.Some support1 report
-
Morgan Stanley and Raymond James Financial raised their price objectives for Elevance Health, Inc. on September 15, 2026.Some support1 report
-
Cantor Fitzgerald, Morgan Stanley, and Royal Bank of Canada issued price target updates for Elevance Health, Inc. on September 12, 2026.Some support1 report
-
Elevance Health and Privia Health Group are both facing market scrutiny.Some support1 report
-
TD Cowen boosted its price objective on Elevance Health, while the National Pension Service reduced its holdings and filed 13F with the SEC.Some support1 report
-
Analysts have raised price targets and ratings for Elevance Health, involving Bank of America, Raymond James Financial, and TD Cowen.Well supported4 reports
-
Tenet Healthcare and Elevance Health, Inc. are noted as companies competing in the large-cap U.S. healthcare market and operating as health benefits providers.Some support1 report
-
CMS raised 2027 payment rates, aiding recovery, while the Trump administration proposed flat reimbursement rates for Medicare.Some support3 reports
-
Berkshire's investment signals suggest a rotation into the healthcare sector, fueled by Buffett's stake in UnitedHealth.Some support1 report1 development inside
-
Elevance Health, Inc. filed reports with the SEC on August 26, 2026.Some support3 reports
Gone quiet
No new reports in 90+ days-
Norges Bank purchased a new position in Elevance Health shares, and Amundi increased its stake in the company.Some support1 report
-
Elevance Health, Inc. filed its required 13F reports regarding institutional holdings with the Securities and Exchange Commission on August 8, 2026.Some support2 reports
-
Greenskeeper Asset Management views Elevance Health, Inc. as a strong contributor to its portfolio performance.Some support2 reports
-
Jefferies Financial Group issued a report on Elevance Health, Inc. on July 31, 2026.Some support1 report
-
Elevance Health, Inc.'s CEO, Gail Boudreaux, was required to file insider transactions with the SEC.Some support2 reports
-
Elevance Health was added to Seth Klarman's investment portfolio.Some support2 reports
-
MidFirst Bank purchased a new stake in Elevance Health shares.Some support1 report
-
Elevance Health, Inc. is involved in a required filing with the SEC after Norges Bank acquired a new stake in the company.Some support1 report
-
Buffett commented on how share prices do not reflect business value, specifically regarding Usio, Inc.Some support12 reports
-
AI stocks offer greater upside potential than Elevance Health, Inc.Some support1 report
-
AI deployment in healthcare is leading to class action lawsuits, affecting major companies including Animation International, UnitedHealth Group, Humana, and Elevance Health.Speculative1 report
-
Elevance Health, Inc. is based in Indianapolis, Indiana.Some support3 reports
-
Wells Fargo maintained a Buy rating on Elevance Health, Inc. on July 6, 2025.Speculative1 report
-
Elevance Health acquired Granular Insurance Company in April 2025, and A. M. Best is reviewing Granular's financial strength rating.Some support1 report
-
Elevance Health, Inc. is facing operational challenges due to rising medical costs in its ACA and Medicaid business.Some support1 report
-
Elevance Health, Inc. reported that its Return on Equity (ROE) was decent compared to the industry average, but moderate returns were not reflected in low growth.Some support1 report
-
Jim Cramer discussed Elevance Health, Inc. among 10 stocks on July 21, 2025.Some support1 report
-
Elevance Health, Inc. and Wells Fargo announced a price target reduction on July 25, 2025, citing margin uncertainty in key segments.Some support1 report
-
Centene Corporation and UnitedHealth Group are facing rising medical costs and scrutiny over aggressive loan repayment practices, watched by Senators Warren and Wyden.Some support1 report1 development inside
-
Baird reduced its price target for Elevance Health, Inc. on August 8, 2025.Some support1 report
-
UBS reiterated a 'Buy' rating on the stock of Elevance Health, Inc. on August 8, 2025.Some support1 report
-
Elevance Health, Humana, and UnitedHealth Group are noted as competitors in the value-based care space.Some support3 reports
-
Financial institutions, including UBS and Deutsche Bank, upgraded Elevance Health to Buy rating on May 28, 2026, while it operates as a health insurer in the United States.Some support1 report
No events began in the chosen period. Widen it, or reset.
What's reaching Elevance Health, Inc.
Events traced to Elevance Health, Inc., step by step, newest firstAround Elevance Health, Inc. this week
News at the entities that move Elevance Health, Inc. most-
Securities and Exchange Commission StructuralDanaher Corporation disclosed filings with the SEC, and Fifth Third Bancorp reduced its position in Danaher.Moves Elevance Health, Inc.
-
Carelon StructuralCarelon's policy expansion is benefiting PAMA's volume, and Mark Gardner is identified as the company president.Moves Elevance Health, Inc.
-
Medicare OperationalGetty Images provided the image source for an article involving Medicare.Moves Elevance Health, Inc.
-
TD Cowen OperationalTD Cowen is based in Toronto.Moves Elevance Health, Inc.
-
SEC StructuralMangoceuticals, a Nasdaq-listed company, filed an offering statement with the SEC and partnered with T7X for tokenized stock issuance.Moves Elevance Health, Inc.
-
UBS Mentioned togetherOnto Innovation participated in investor conferences hosted by Morgan Stanley and UBS at the New York Stock Exchange.Moves Elevance Health, Inc.
Connections
The 29 strongest of 68, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Carelon Structural
Carelon functions as a branded operational segment contributing to the overall growth and financial health of Elevance Health.
-
Securities and Exchange Commission Structural
Elevance Health must comply with SEC regulations by filing mandatory 13F reports regarding institutional holdings and share purchases.
-
Gail Boudreaux Structural
Gail Boudreaux serves as the President and CEO of Elevance Health, Inc.
-
SEC Structural
Elevance Health is subject to formal regulatory oversight by the SEC regarding financial filings and market activities.
-
Medicare Operational
Medicare's regulatory actions and reimbursement proposals directly influence the operations and financial stability of Elevance Health.
-
Truist Financial Mentioned together
Truist Financial provides financial analyst coverage, including buy ratings and price target increases, for Elevance Health.
-
Seth Klarman Operational
Seth Klarman holds and recommends Elevance Health as a value stock in his investment portfolio.
-
Norges Bank Transactional
Norges Bank acquired a new stake in Elevance Health, Inc. through a purchase of shares.
Show all 29 connections
-
fund Structural
The fund holds Elevance Health as a current portfolio asset that contributes to the fund's overall performance.
-
MidFirst Bank Transactional
MidFirst Bank purchased a new stake in Elevance Health shares.
-
UBS Mentioned together
no direct coupling
-
Leerink partners Mentioned together
Leerink Partners provides financial analysis and target price objectives for Elevance Health.
-
TD Cowen Operational
TD Cowen actively influences Elevance Health's market valuation by issuing price objectives and stock upgrades.
-
National Pension Service Transactional
The National Pension Service reduced its investment stake in Elevance Health stock.
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group provides financial analysis, including target price adjustments and ratings, for Elevance Health, Inc.
-
Morgan Stanley Mentioned together
Morgan Stanley provides financial research and price target analysis for Elevance Health.
-
Tenet Healthcare Operational
Tenet Healthcare and Elevance Health compete within the large-cap healthcare market.
-
Humana Operational
Both entities are major competitors operating in the managed healthcare and value-based care markets.
-
Bank of America Mentioned together
Bank of America provides analyst coverage, including target price ratings, for Elevance Health.
-
Frankfurt Shared context
A major European financial hub where companies like Elevance operate.
-
Royal Bank of Canada Mentioned together
The evidence tracked Royal Bank of Canada's market movements, including price target reductions and sector rating changes, but made no mention of Elevance Health.
-
Wells Fargo Mentioned together
Wells Fargo provides financial ratings and analysis on Elevance Health.
-
Cantor Fitzgerald Mentioned together
Cantor Fitzgerald published market analysis on Elevance Health, including raising price objectives and overweight ratings.
-
Amundi Transactional
Amundi has increased its financial stake in Elevance Health, Inc.
-
Raymond James Financial Mentioned together
Both companies are publicly traded entities whose stock valuations are influenced by external analyst reports.
-
New York Shared context
Elevance Health operates within the geographical context of New York.
-
Indianapolis Shared context
Elevance Health, Inc. is based in Indianapolis.
-
Deutsche Bank Mentioned together
Evidence suggests Elevance Health received a Buy rating upgrade, but no interaction with Deutsche Bank was documented in the available snapshot.
-
Warren Buffett Mentioned together
No evidence was provided linking Warren Buffett to Elevance Health, Inc.
History
Events by the month they beganNovember 2026
1 eventOctober 2026
2 eventsSeptember 2026
5 events- Morgan Stanley and Raymond James Financial raised their price objectives for Elevance Health, Inc. on September 15, 2026.
- Cantor Fitzgerald, Morgan Stanley, and Royal Bank of Canada issued price target updates for Elevance Health, Inc. on September 12, 2026.
- Elevance Health and Privia Health Group are both facing market scrutiny.
- TD Cowen boosted its price objective on Elevance Health, while the National Pension Service reduced its holdings and filed 13F with the SEC.
- Tenet Healthcare and Elevance Health, Inc. are noted as companies competing in the large-cap U.S. healthcare market and operating as health benefits providers.
Show 3 earlier months
August 2026
4 events- Elevance Health, Inc. filed reports with the SEC on August 26, 2026.
- Norges Bank purchased a new position in Elevance Health shares, and Amundi increased its stake in the company.
- Elevance Health, Inc. filed its required 13F reports regarding institutional holdings with the Securities and Exchange Commission on August 8, 2026.
- Greenskeeper Asset Management views Elevance Health, Inc. as a strong contributor to its portfolio performance.
July 2026
4 events- Truist Financial raised its price objective and issued a buy rating for Elevance Health, Inc. on July 4, 2026.
- Analysts have raised price targets and ratings for Elevance Health, involving Bank of America, Raymond James Financial, and TD Cowen.
- Jefferies Financial Group issued a report on Elevance Health, Inc. on July 31, 2026.
- Elevance Health, Inc.'s CEO, Gail Boudreaux, was required to file insider transactions with the SEC.
June 2026
22 events- Elevance Health offers services through Carelon brand.
- CMS rating changes affect major insurers like Humana, Centene, and Elevance, leading to legal challenges and financial adjustments.
- CMS raised 2027 payment rates, aiding recovery, while the Trump administration proposed flat reimbursement rates for Medicare.
- Berkshire's investment signals suggest a rotation into the healthcare sector, fueled by Buffett's stake in UnitedHealth.
- Elevance Health was added to Seth Klarman's investment portfolio.
- MidFirst Bank purchased a new stake in Elevance Health shares.
- Elevance Health, Inc. is involved in a required filing with the SEC after Norges Bank acquired a new stake in the company.
- Buffett commented on how share prices do not reflect business value, specifically regarding Usio, Inc.
- AI stocks offer greater upside potential than Elevance Health, Inc.
- AI deployment in healthcare is leading to class action lawsuits, affecting major companies including Animation International, UnitedHealth Group, Humana, and Elevance Health.
- Elevance Health, Inc. is based in Indianapolis, Indiana.
- Wells Fargo maintained a Buy rating on Elevance Health, Inc. on July 6, 2025.
- Elevance Health acquired Granular Insurance Company in April 2025, and A. M. Best is reviewing Granular's financial strength rating.
- Elevance Health, Inc. is facing operational challenges due to rising medical costs in its ACA and Medicaid business.
- Elevance Health, Inc. reported that its Return on Equity (ROE) was decent compared to the industry average, but moderate returns were not reflected in low growth.
- Jim Cramer discussed Elevance Health, Inc. among 10 stocks on July 21, 2025.
- Elevance Health, Inc. and Wells Fargo announced a price target reduction on July 25, 2025, citing margin uncertainty in key segments.
- Centene Corporation and UnitedHealth Group are facing rising medical costs and scrutiny over aggressive loan repayment practices, watched by Senators Warren and Wyden.
- Baird reduced its price target for Elevance Health, Inc. on August 8, 2025.
- UBS reiterated a 'Buy' rating on the stock of Elevance Health, Inc. on August 8, 2025.
- Elevance Health, Humana, and UnitedHealth Group are noted as competitors in the value-based care space.
- Financial institutions, including UBS and Deutsche Bank, upgraded Elevance Health to Buy rating on May 28, 2026, while it operates as a health insurer in the United States.